Skip to main content
Article thumbnail
Location of Repository

SUGGESTIONS FOR CLINICAL CARE

By 

Abstract

There is limited evidence to suggest that the progression of certain forms of renal disease are retarded by ibopamine. (Level II evidence; single RCT with suboptimal design; clinically relevant outcome; moderately strong effect) However, this benefit is outweighed by the serious side-effects of ibopamine (3-fold increased risk of death) and its use cannot be recommended

Year: 2004
OAI identifier: oai:CiteSeerX.psu:10.1.1.362.9240
Provided by: CiteSeerX
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://citeseerx.ist.psu.edu/v... (external link)
  • http://www.cari.org.au/CKD_Pre... (external link)
  • Suggested articles


    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.